PEIRX | VTMNX | PEIRX / VTMNX | |
Total Expense Ratio | 0.90 | 0.03 | 3,000% |
Annual Report Gross Expense Ratio | 1.41 | 0.03 | 4,700% |
Fund Existence | 7 years | 24 years | - |
Gain YTD | 5.811 | 7.161 | 81% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 892M | 205B | 0% |
Annual Yield % from dividends | 4.15 | 3.07 | 135% |
Returns for 1 year | -6.04 | 3.12 | -193% |
Returns for 3 years | -8.78 | 7.01 | -125% |
Returns for 5 years | 39.52 | 64.62 | 61% |
Returns for 10 years | N/A | 32.92 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 19.65 | 0.70 | +3.69% |
ProShares UltraShort Nasdaq Biotech | |||
NOCT | 48.60 | -1.58 | -3.15% |
Innovator Growth-100 Pwr Buff ETF™ Oct | |||
ETB | 13.29 | -0.48 | -3.49% |
Eaton Vance Tax-Managed Buy-Write Income Fund | |||
XUSP | 35.82 | -2.00 | -5.30% |
Innovator Uncapped Accelerated US Eq ETF | |||
BBMC | 85.87 | -6.26 | -6.79% |
JPMorgan BetaBuilders US Mid Cap Eq ETF |